A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza; Bente Lund; Jacob Christian Lindegaard; Nina Keldsen; Anders Mellemgaard; René Depont Christensen; Kamma Bertelsen

doi:10.1016/j.ygyno.2010.06.022

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, Nina Keldsen, Anders Mellemgaard, René Depont Christensen, Kamma Bertelsen

Research output: Contribution to journal › Journal article › Research › peer-review

11 Citations (Scopus)

Abstract

Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

Original language	English
Journal	Gynecologic Oncology
Volume	119
Pages (from-to)	26-31
Number of pages	6
ISSN	0090-8258
DOIs	https://doi.org/10.1016/j.ygyno.2010.06.022
Publication status	Published - 1 Oct 2010
Externally published	Yes

Bibliographical note

Keywords

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Cystadenocarcinoma, Serous
Deoxycytidine
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin
Female
Humans
Middle Aged
Ovarian Neoplasms
Polyethylene Glycols
Survival Rate

Access to Document

10.1016/j.ygyno.2010.06.022

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{5e63fc592cad4527bb10b12c542b6da9,

title = "A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin",

abstract = "Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.",

keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cystadenocarcinoma, Serous, Deoxycytidine, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Female, Humans, Middle Aged, Ovarian Neoplasms, Polyethylene Glycols, Survival Rate",

author = "Mirza, {Mansoor Raza} and Bente Lund and Lindegaard, {Jacob Christian} and Nina Keldsen and Anders Mellemgaard and Christensen, {Ren{\'e} Depont} and Kamma Bertelsen",

year = "2010",

month = oct,

day = "1",

doi = "10.1016/j.ygyno.2010.06.022",

language = "English",

volume = "119",

pages = "26--31",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press",

}

TY - JOUR

T1 - A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

AU - Mirza, Mansoor Raza

AU - Lund, Bente

AU - Lindegaard, Jacob Christian

AU - Keldsen, Nina

AU - Mellemgaard, Anders

AU - Christensen, René Depont

AU - Bertelsen, Kamma

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

AB - Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Cystadenocarcinoma, Serous

KW - Deoxycytidine

KW - Disease-Free Survival

KW - Dose-Response Relationship, Drug

KW - Doxorubicin

KW - Female

KW - Humans

KW - Middle Aged

KW - Ovarian Neoplasms

KW - Polyethylene Glycols

KW - Survival Rate

U2 - 10.1016/j.ygyno.2010.06.022

DO - 10.1016/j.ygyno.2010.06.022

M3 - Journal article

SN - 0090-8258

VL - 119

SP - 26

EP - 31

JO - Gynecologic Oncology

JF - Gynecologic Oncology

ER -

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Abstract

Bibliographical note

Keywords

Access to Document

AUB Link

Fingerprint

Cite this